204 related articles for article (PubMed ID: 33065341)
41. Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activated receptor-α.
Scuderi C; Valenza M; Stecca C; Esposito G; Carratù MR; Steardo L
J Neuroinflammation; 2012 Mar; 9():49. PubMed ID: 22405189
[TBL] [Abstract][Full Text] [Related]
42. Bile acids induce visceral hypersensitivity via mucosal mast cell-to-nociceptor signaling that involves the farnesoid X receptor/nerve growth factor/transient receptor potential vanilloid 1 axis.
Li WT; Luo QQ; Wang B; Chen X; Yan XJ; Qiu HY; Chen SL
FASEB J; 2019 Feb; 33(2):2435-2450. PubMed ID: 30260705
[TBL] [Abstract][Full Text] [Related]
43. Palmitoylethanolamide reduces early renal dysfunction and injury caused by experimental ischemia and reperfusion in mice.
Di Paola R; Impellizzeri D; Mondello P; Velardi E; Aloisi C; Cappellani A; Esposito E; Cuzzocrea S
Shock; 2012 Oct; 38(4):356-66. PubMed ID: 22772472
[TBL] [Abstract][Full Text] [Related]
44. Effects of palmitoylethanolamide on immunologically induced histamine, PGD2 and TNFalpha release from canine skin mast cells.
Cerrato S; Brazis P; della Valle MF; Miolo A; Puigdemont A
Vet Immunol Immunopathol; 2010 Jan; 133(1):9-15. PubMed ID: 19625089
[TBL] [Abstract][Full Text] [Related]
45. Basal and fasting/refeeding-regulated tissue levels of endogenous PPAR-alpha ligands in Zucker rats.
Izzo AA; Piscitelli F; Capasso R; Marini P; Cristino L; Petrosino S; Di Marzo V
Obesity (Silver Spring); 2010 Jan; 18(1):55-62. PubMed ID: 19521349
[TBL] [Abstract][Full Text] [Related]
46. Patients with dyspepsia have impaired mucosal integrity both in the duodenum and jejunum: in vivo assessment of small bowel mucosal integrity using baseline impedance.
Nakagawa K; Hara K; Fikree A; Siddiqi S; Woodland P; Masamune A; Aziz Q; Sifrim D; Yazaki E
J Gastroenterol; 2020 Mar; 55(3):273-280. PubMed ID: 31468184
[TBL] [Abstract][Full Text] [Related]
47. Upregulation of Vanilloid Receptor-1 in Functional Dyspepsia With or Without Helicobacter pylori Infection.
Choi YJ; Kim N; Kim J; Lee DH; Park JH; Jung HC
Medicine (Baltimore); 2016 May; 95(19):e3410. PubMed ID: 27175641
[TBL] [Abstract][Full Text] [Related]
48. Palmitoylethanolamide reduces inflammation and itch in a mouse model of contact allergic dermatitis.
Vaia M; Petrosino S; De Filippis D; Negro L; Guarino A; Carnuccio R; Di Marzo V; Iuvone T
Eur J Pharmacol; 2016 Nov; 791():669-674. PubMed ID: 27720681
[TBL] [Abstract][Full Text] [Related]
49. Intestinal immune activation in presumed post-infectious functional dyspepsia.
Kindt S; Tertychnyy A; de Hertogh G; Geboes K; Tack J
Neurogastroenterol Motil; 2009 Aug; 21(8):832-e56. PubMed ID: 19460107
[TBL] [Abstract][Full Text] [Related]
50. Activation of Eosinophils and Mast Cells in Functional Dyspepsia: an Ultrastructural Evaluation.
Vanheel H; Vicario M; Boesmans W; Vanuytsel T; Salvo-Romero E; Tack J; Farré R
Sci Rep; 2018 Mar; 8(1):5383. PubMed ID: 29599471
[TBL] [Abstract][Full Text] [Related]
51. Peroxisome proliferator-activated receptor α mediates acute effects of palmitoylethanolamide on sensory neurons.
Khasabova IA; Xiong Y; Coicou LG; Piomelli D; Seybold V
J Neurosci; 2012 Sep; 32(37):12735-43. PubMed ID: 22972997
[TBL] [Abstract][Full Text] [Related]
52. A pilot study on duodenal acid exposure and its relationship to symptoms in functional dyspepsia with prominent nausea.
Lee KJ; Demarchi B; Demedts I; Sifrim D; Raeymaekers P; Tack J
Am J Gastroenterol; 2004 Sep; 99(9):1765-73. PubMed ID: 15330916
[TBL] [Abstract][Full Text] [Related]
53. Analysis of TRPV channel activation by stimulation of FCεRI and MRGPR receptors in mouse peritoneal mast cells.
Solís-López A; Kriebs U; Marx A; Mannebach S; Liedtke WB; Caterina MJ; Freichel M; Tsvilovskyy VV
PLoS One; 2017; 12(2):e0171366. PubMed ID: 28158279
[TBL] [Abstract][Full Text] [Related]
54. Micro-inflammation in functional dyspepsia: A systematic review and meta-analysis.
Du L; Chen B; Kim JJ; Chen X; Dai N
Neurogastroenterol Motil; 2018 Apr; 30(4):e13304. PubMed ID: 29392796
[TBL] [Abstract][Full Text] [Related]
55. The role of transient receptor potential vanilloid receptor 1 and peroxisome proliferator-activated receptors-α in mediating the antinociceptive effects of palmitoylethanolamine in rats.
Aldossary SA; Alsalem M; Kalbouneh H; Haddad M; Azab B; Al-Shboul O; Mustafa AG; Obiedat S; El-Salem K
Neuroreport; 2019 Jan; 30(1):32-37. PubMed ID: 30418420
[TBL] [Abstract][Full Text] [Related]
56. Palmitoylethanolamide Exerts Antiproliferative Effect and Downregulates VEGF Signaling in Caco-2 Human Colon Carcinoma Cell Line Through a Selective PPAR-α-Dependent Inhibition of Akt/mTOR Pathway.
Sarnelli G; Gigli S; Capoccia E; Iuvone T; Cirillo C; Seguella L; Nobile N; D'Alessandro A; Pesce M; Steardo L; Cuomo R; Esposito G
Phytother Res; 2016 Jun; 30(6):963-70. PubMed ID: 26929026
[TBL] [Abstract][Full Text] [Related]
57. Increased levels of palmitoylethanolamide and other bioactive lipid mediators and enhanced local mast cell proliferation in canine atopic dermatitis.
Abramo F; Campora L; Albanese F; della Valle MF; Cristino L; Petrosino S; Di Marzo V; Miragliotta V
BMC Vet Res; 2014 Jan; 10():21. PubMed ID: 24423192
[TBL] [Abstract][Full Text] [Related]
58. Palmitoylethanolamide protects dentate gyrus granule cells via peroxisome proliferator-activated receptor-α.
Koch M; Kreutz S; Böttger C; Benz A; Maronde E; Ghadban C; Korf HW; Dehghani F
Neurotox Res; 2011 Feb; 19(2):330-40. PubMed ID: 20221904
[TBL] [Abstract][Full Text] [Related]
59. PPARα-Dependent Effects of Palmitoylethanolamide Against Retinal Neovascularization and Fibrosis.
Ye S; Chen Q; Jiang N; Liang X; Li J; Zong R; Huang C; Qiu Y; Ma JX; Liu Z
Invest Ophthalmol Vis Sci; 2020 Apr; 61(4):15. PubMed ID: 32298438
[TBL] [Abstract][Full Text] [Related]
60. Effects of intra-ventrolateral periaqueductal grey palmitoylethanolamide on thermoceptive threshold and rostral ventromedial medulla cell activity.
de Novellis V; Luongo L; Guida F; Cristino L; Palazzo E; Russo R; Marabese I; D'Agostino G; Calignano A; Rossi F; Di Marzo V; Maione S
Eur J Pharmacol; 2012 Feb; 676(1-3):41-50. PubMed ID: 22178921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
